About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNNCT05253560

Prodromal Parkinsonian Features in GBA1 Mutation Carriers

Objective of the trial. To define a sub-population which is at increased risk of developing Parkinson, beyond the fact of carrying Gaucher; in this sub-population the investigators shall conduct a com...

Lead sponsor: Shaare Zedek Medical Center•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Contacts

Ari Zimran, MD

CONTACT

+972-509149149 azimran@gmail.com

Michal Becker- Cohen, M.Sc.

CONTACT

+972-504606310 michalbec@gmail.com

Sponsors

Lead Sponsor

Shaare Zedek Medical Center

The carriers, the healthy people and the Gaucher patients will undergo a number of non-invasive tests, which test the pre-Parkinson signs. The tests are based on various sense tests, blood tests, measuring of blood pressure, lying and standing, ultra-sound of the brain and a neurological test (test of the nervous system and various questionnaires).

Age

40 - 75 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Willing to participate

Exclusion Criteria

•PD patients
•Dementia

Related studies

RECRUITINGPhase 1

A Study to Compare the Amount of Two Forms of Tafamidis in the Blood of Healthy Adults Under Fed Conditions

NCT07470866 · Healthy

Cytapheresis of Volunteer Donors

NCT00104325 · Healthy Volunteers

Sodium vs Potassium Education to Improve Vascular Health

NCT07221448 · Healthy

RECRUITINGPhase 1

A First-in-human Study of the Safety of an Immunosuppressive Antibody (IMP761) in Healthy Volunteers

NCT06637865 · Healthy

RECRUITINGPhase 1

A Clinical Study of MK-4082 in Healthy Overweight Participants (MK-4082-002)

NCT07388667 · Healthy

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 24, 2023Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment600

Start dateMay 2017

Last updatedNov 24, 2023

Condition

Gaucher Disease, Type 1 Healthy

Locations shown

Michal Becker- Cohen

Jerusalem, Please Select...

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 24, 2023Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions